Purchase Order N0017313P3497
- Not listed
- The Office of Naval Research awarded a $5,675.74 firm fixed-price purchase order to Illumina, Inc. for laboratory supplies on May 5, 2017, with an ultimate completion date of August 3, 2017. The contract, issued without a set-aside designation, will be performed in San Diego, California, where Illumina maintains its headquarters. This purchase order represents a routine procurement of laboratory consumables and supplies from the biotechnology company, which specializes in genetic sequencing...
- This federal contract award was issued by the Office of Naval Research (ONR), a defense agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $23,256.48 firm fixed-price purchase order is for a reagent kit (PR# 69-5525-18) with a completion date of November 26, 2018. The contract does not utilize any set-aside designations. Illumina is a specialized technology provider that has been awarded numerous prime federal contracts and grants...
- <p>The Office of Naval Research awarded a purchase order to Illumina, Inc. valued at $15,610.40 for reagent kits, with an award date of September 18, 2012 and ultimate completion date of October 9, 2012. Place of performance is San Diego, California. The order carries firm fixed-price pricing and no set-aside designation.</p>
- <p>The Office of Naval Research awarded a purchase order to Illumina, Inc. for reagent kits valued at $9,495.20 on July 2, 2019, with completion by August 2, 2019. Place of performance is San Diego, California. The order is firm fixed price with no set-aside designation. No Service Contract Inventory reporting is present in the source.</p>
- The Office of Naval Research awarded a $7,422 firm fixed-price purchase order to Illumina, Inc. on June 15, 2015, for Ribo-Zero Magnetic products, with a completion date of July 31, 2015. The contract, executed without a set-aside designation, was performed in San Diego, California, where Illumina maintains its headquarters. Ribo-Zero Magnetic reagents are specialized consumables used in genomic research workflows to deplete ribosomal RNA from samples prior to RNA sequencing, enabling...
- The Office of Naval Research awarded a $15,000 firm fixed-price purchase order to Illumina, Inc. on July 10, 2014, for the MiSeq Silver Contract, with completion targeted for July 9, 2015. The contract, which carries no set-aside designation, will be performed in San Diego, California. Illumina, a biotechnology company specializing in genetic sequencing and genomic analysis technologies, will deliver products or services supporting the Navy's research initiatives. The MiSeq platform is one of...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- The Office of Naval Research awarded a $15,965 firm fixed-price purchase order to Illumina, Inc. for MiSeq Annual Service on July 10, 2015, with completion scheduled for July 9, 2016. The contract, which did not utilize a set-aside designation, covers maintenance and support services for Illumina's MiSeq DNA sequencing instrument at the contractor's San Diego, California location. Illumina is a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies,...
- <p>The Office of Naval Research awarded a purchase order to Illumina, Inc. valued at $31,592.90 on August 17, 2017. Place of performance is San Diego, California. The order is for firm fixed-price commercial biotechnology equipment or services, with ultimate completion scheduled for September 15, 2017. No small business set-aside was applied.</p>
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
The Office of Naval Research awarded a $16,302 firm fixed-price purchase order to Illumina, Inc. for reagent kits on September 26, 2013, with completion targeted for October 26, 2013. The contract, issued without a set-aside designation, will be performed in San Diego, California. Illumina is a biotechnology company specializing in genetic sequencing and genomic analysis technologies, providing DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software to federal agencies across both civilian and defense sectors. This purchase order represents a discrete procurement of laboratory reagents to support ONR's genomic research initiatives. The relatively modest contract value and compressed timeline typical of purchase orders reflect a straightforward procurement of specialized consumables for immediate use. Illumina's established position as a primary supplier of sequencing technologies and associated reagent kits to federal agencies positions it as a critical provider for research operations requiring advanced genomic capabilities, consistent with the company's extensive contracting history across multiple federal agencies including the NIH, USDA, and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 9/25/13 |